Division of Dermatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Division of Dermatology, Department of Medicine, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
J Cosmet Dermatol. 2022 Oct;21(10):4470-4478. doi: 10.1111/jocd.15190. Epub 2022 Jul 27.
During the ongoing COVID-19 outbreak, face mask use has increased and became a part of our daily lives. While wearing, prolonged contact time and microenvironmental change profoundly lead to an acne flare-up, defined as "maskne."
We aimed to assess the efficacy and safety of snail secretion filtrate, Calendula officinalis, and Glycyrrhiza glaba root extract combination serum (SCGS) in treating the maskne.
This was a randomized, double-blind, placebo-controlled trial study. This study enrolled 66 participants with mild-to-moderate maskne. The SCGS and placebo were randomly assigned for participants to use twice daily for 12 weeks. Percentage change of acne lesion count, acne severity by Investigator Global Evaluation Acne (IGEA), sebum levels, corneometry levels, transepidermal water loss (TEWL), erythema score by Visia®, and adverse events were evaluated 4-weekly at baseline to Week 12. At Week 12, all participants evaluated their satisfaction scores using a 10-point visual analog scale (VAS).
In the mask-covered area, the percent reduction in inflammatory acne lesions from the treatment group was significantly greater than the placebo group at all time points (coefficient of percentage change of inflammatory lesions = -33.89 [95% CI -65.24, -2.53]; p = 0.03). Also, a subgroup analysis with participants using concurrent acne treatments revealed similar results (12 participants, coefficient = -50.30 [95% -88.65, -11.95]; p = 0.01). However, there were no significant differences in non-inflammatory lesions, all skin biophysics, and VAS between groups. Adverse events were mild and occurred in a few cases in both groups.
The SCGS could significantly improve inflammatory acne lesions and had a favorable tolerability profile, suggesting its role as an adjunctive treatment in maskne.
在持续的 COVID-19 大流行期间,人们越来越多地使用口罩,口罩已成为我们日常生活的一部分。在佩戴口罩时,长时间的接触和微环境的变化会导致痤疮恶化,即“口罩痘”。
我们旨在评估蜗牛分泌物滤液、金盏花和甘草根提取物组合血清(SCGS)治疗“口罩痘”的疗效和安全性。
这是一项随机、双盲、安慰剂对照试验研究。这项研究纳入了 66 名患有轻至中度“口罩痘”的参与者。将 SCGS 和安慰剂随机分配给参与者,每天使用两次,持续 12 周。在基线至 12 周时,每 4 周评估痤疮皮损计数的百分比变化、研究者全球评估痤疮(IGEA)的痤疮严重程度、皮脂水平、角质层水平、经表皮水分流失(TEWL)、Visia®的红斑评分,以及不良反应。在第 12 周,所有参与者使用 10 分视觉模拟量表(VAS)评估他们的满意度评分。
在口罩覆盖区域,治疗组的炎性痤疮皮损百分比减少在所有时间点均显著大于安慰剂组(炎症性病变百分比变化系数=-33.89 [95%CI -65.24, -2.53];p=0.03)。此外,对同时使用痤疮治疗的参与者进行亚组分析,结果相似(12 名参与者,系数=-50.30 [95% -88.65, -11.95];p=0.01)。然而,两组之间在非炎性病变、所有皮肤生物物理特性和 VAS 方面均无显著差异。不良反应轻微,两组均有少数病例发生。
SCGS 可显著改善炎性痤疮皮损,具有良好的耐受性,表明其可作为“口罩痘”的辅助治疗。